Guangxi VERYARK Technology Co., Ltd focus on the anesthesia equipment research and development, production and sales. In 2000 ,VERYARK successfully developed TCI (target-controlled infusion) pump in Beijing and introduced it in 2002，which has broken the monopoly situation of foreign products, opening a new chapter to the development of domestic intravenous anesthesia. In 2005, VERYARK moved from Beijing to Nanning, a transit point between China and ASEAN to make re-registration. 

In order to solve the individual difference, In 2008,VERYARK start to develop Closed-Loop Muscle Relaxant Infusion System. With strong R & D capability and after three years of research and development, the product’s CLMRIS-I had been launched in November 2010.The product has two patents- utility models and sensor utility model. In the same year, also introduced CONCERT-I (the three channels system with closed - loop muscle relaxant, TCI and analgesic). In 2012,Muscle Relaxant Monitor (Veryark-TOF)was introduced. In order to win the market opportunities, VERYARK successfully developed CONCERT-CL closed-loop infusion system in 2014. This product also obtains the patent certificate of "Closed-loop muscle relaxant infusion system" -design patent certificate and utility model patent certificate, "Muscle tension sensor" -utility model patent certificate, " Anesthesia drug balance control device and its control method "- invention patent certificate (patent number: ZL 2014 1 0041325.4).

 In 2016,the product’s CONCERT-CLE which integrated closed-loop infusion system was introduced. In the same year, VERYRK with Beijing Children's Hospital, Sichuan Huaxi Medical University Hospital ,Wenzhou Medical University Affiliated Hospital jointly study the Pediatric anesthesia program. Between 2014 and 2016, CONCERT-CL has been widely used in more than 2,000 cases of clinical trials at home and abroad, being highly recognized and praised by a majority of medical staff, and anesthesiologist.